期刊文献+

MRI定量肝脏及心脏铁过载对地中海贫血全相合造血干细胞移植的影响 被引量:5

Liver and cardiac iron overload is harmful to HLA-identical hematopoietic stem cell transplantation in thalassemia children: an MRI detection
下载PDF
导出
摘要 背景:大部分的重型β-地中海贫血患儿都存在铁过载的情况,而铁过载可对造血干细胞移植产生不利影响。目的:利用MRI T2*检测肝脏及心脏铁过载情况,从而评估肝脏、心脏铁过载对重型β-地中海贫血患儿全相合异基因造血干细胞移植的影响。方法:对81例全相合异基因造血干细胞移植、年龄>3岁,能配合MRI检测的重型β-地中海贫血患儿,进行肝脏及心脏MRI T2*检测。根据检测结果计算出肝脏及心脏铁浓度,作为评价肝心铁过载的指标,并将肝脏、心脏铁浓度与患儿血清铁蛋白、造血重建时间、死亡率、植入率、移植后常见并发症的发病率,如移植物抗宿主病、感染、免疫性溶血、全血细胞减少、肝静脉阻塞病、败血症进行相关因素分析。结果与结论:肝脏铁浓度与血红蛋白植入时间呈正相关(r=0.229,P=0.043),心脏铁浓度与死亡率呈正相关(r=0.266,P=0.017),血清铁蛋白与植入率呈负相关(r=-0.289,P=0.009),血清铁蛋白与败血症发病率呈正相关(r=0.251,P=0.024),血清铁蛋白与全血细胞减少发病率呈正相关(r=0.276,P=0.013)。由此可见,铁过载可对重型β-地中海贫血患儿全相合异基因造血干细胞移植产生不利影响。因此,对行造血干细胞移植的β-地中海贫血患儿综合进行血清铁蛋白、肝脏及心脏铁过载的评估非常必要。 BACKGROUND:The majority of children withβ-thalassemia major have iron overload,and iron overload may have negative effects on hematopoietic stem cell transplantation.OBJECTIVE:To assess the effects of liver and cardiac iron overload detected by magnetic resonance imaging(MRI)T2*on HLA-identical allogeneic hematopoietic stem cell transplantation in children withβ-thalassemia major.METHODS:Eighty-one children withβ-thalassemia major who were over3years of age and could cooperate with MRI detection were subjected to liver and heart MRI T2*tests before or after HLA-identical allogeneic hematopoietic stem cell transplantation.According to the test results,we calculated the liver and cardiac iron content,defined as an indicator of liver and heart iron overload.Then,there was a correlation analysis between the liver and cardiac iron content and serum ferritin,time of hematopoietic reconstitution,mortality rate,implantation rate and the morbidity of transplantation related complications,such as graft-versus-host disease,infections,autoimmune hemolysis,pancytopenia,hepatic veno-occlusive disease,septicemia.RESULTS AND CONCLUSION:The liver iron content was positively correlated with the time of hemoglobin implantation(r=0.229,P=0.043),and the cardiac iron content were positively correlated with the mortality rate(r=0.266,P=0.017);the serum ferritin level was negatively correlated with the implantation rate(r=-0.289,P=0.009),and positively correlated with the morbidity of septicemia(r=0.251,P=0.024)and pancytopenia(r=0.276,P=0.013).Therefore,iron overload exerts negative effects on HLA-identical allogeneic hematopoietic stem cell transplantation inβ-thalassemia major children,and it is necessary to detect serum ferritin level and assess liver and cardiac iron overload before cell transplantation.
作者 阳文景 廖建云 温建芸 阮永胜 陈丽白 何岳林 李春富 吴学东 Yang Wen-jing;Liao Jian-yun;Wen Jian-yun;Ruan Yong-sheng;Chen Li-bai;He Yue-lin;Li Chun-fu;Wu Xue-dong(Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China;Department of Pediatrics, Liuzhou Municipal Liutie Central Hospital, Liuzhou 545007, Guangxi Zhuang Autonomous Region, China)
出处 《中国组织工程研究》 CAS 北大核心 2017年第33期5293-5298,共6页 Chinese Journal of Tissue Engineering Research
基金 广东省科技计划项目(2014A020212186) 南方医院院长基金(2014B012)~~
关键词 干细胞 移植 重型Β地中海贫血 铁过载 造血干细胞移植 核磁共振T2* 肝铁浓度 心铁浓度 血清铁蛋白 败血症 植入率 血红蛋白植入时间 beta-Thalassemia Hematopoietic Stem Cell Transplantation Iron Overload Magnetic Resonance Imaging Tissue Engineering
  • 相关文献

参考文献9

二级参考文献103

  • 1韩伟,陆道培,黄晓军,刘开彦,陈欢,许兰平,刘代红,江倩,陈育红,路瑾,王静波,吴彤,董陆佳,任汉云.HLA配型不合造血干细胞移植GIAC方案100例临床分析[J].中华血液学杂志,2004,25(8):453-457. 被引量:68
  • 2黄晓军,韩伟,许兰平,陈欢,刘代红,陈育红,江倩,路瑾,刘开彦,任汉云,陆道培.HLA配型不合情况下造血干细胞移植的新方法[J].北京大学学报(医学版),2004,36(3):229-233. 被引量:26
  • 3沈亦逵.重型β地中海贫血的治疗进展[J].实用医学杂志,1995,11(3):184-186. 被引量:4
  • 4ModeU B, Khan M, Darlinson M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet, 2000, 355 (9220) :2051-2052.
  • 5Pippard MJ. Iron metabolism and iron chelation in the thalassaemia disorders. Haematologica, 1990,75 ( Suppl 5 ) : 66 -71.
  • 6Chan YL, Li CK, Pang LM, et al. Desferrioxamine-induced long bone changes in thalassaemlc patients - radiographic features, prevalence and relations with growth. Clin Radiol,2000,55:610-614.
  • 7Gabutti V, Piga A. Results of long term iron-chelating therapy. Acta Haematol, 1996,95:26-36.
  • 8Kattamis A, Dinopoulos A, Ladis V, et al. Variations of ferritin levels over a period of 15 years as a compliance chelation index in thalassemic patients. Am J Haemato1,2001,68 :221-224.
  • 9Caro J, Huybrenchts KF, Green TC. Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desfenloxamine for treatment of iron overload in thalassemia major: a systematic review. BMC Blood Disord ,2002,2:4.
  • 10Pennel D J, Berdoukas V, Karagiorga M, et al. Randomized controlled trial of defefiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial sidemsis. Blood,2006, 107:3738-3744.

共引文献136

同被引文献37

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部